Safety, Resistance, and Efficacy Results from a Phase IIIb Study of Conventional- and Double-Dose Oseltamivir Regimens for Treatment of Influenza in Immunocompromised Patients

INTRODUCTION: Immunocompromised patients infected with influenza exhibit prolonged viral shedding and higher risk of resistance. Optimized treatment strategies are needed to reduce the risk of antiviral resistance. This phase IIIb, randomized, double-blind study (NCT00545532) evaluated conventional-...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Infect Dis Ther
Main Authors: Mitha, Essack, Krivan, Gergely, Jacobs, Frederique, Nagler, Arnon, Alrabaa, Sally, Mykietiuk, Analia, Kenwright, Andrew, Le Pogam, Sophie, Clinch, Barry, Vareikiene, Loreta
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Healthcare 2019
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6856247/
https://ncbi.nlm.nih.gov/pubmed/31667696
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40121-019-00271-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados